Risk of hepatic events in patients treated with vancomycin in clinical studies: a systematic review and meta-analysis.

Background: Routine surveillance of spontaneous reporting data and subsequent disproportionality analyses have indicated that the use of vancomycin might be associated with an increased risk of hepatic events.